Research programme: leukotriene D4 receptor agonists - Sun Pharma Advanced Research Company
Alternative Names: SUN L731Latest Information Update: 23 Aug 2023
Price :
$50 *
At a glance
- Originator Sun Pharma Advanced Research Company
- Class Small molecules
- Mechanism of Action Leukotriene D4 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Asthma
Most Recent Events
- 23 Aug 2023 Discontinued - Preclinical for Asthma in India (unspecified route) (Sun Pharma Advanced Research Company pipeline, August 2023)
- 28 Mar 2018 No recent reports of development identified for preclinical development in Asthma in India